PR Newswire
Curis Consents First Six Patients in TakeAim CLL Study
LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, tod…
PR Newswire
Textured Vegetable Protein Market worth $2.79 billion by 2031- Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., July 6, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the textured vegetable protein market is projected to grow from USD 2.00 billion in 2026 and to reach USD 2.79 billion by 2031, at a Co…
PR Newswire
New Study Reveals Powerful New Method Can Distinguish Schizophrenia from Healthy Using Brain SPECT Imaging
COSTA MESA, Calif., July 6, 2026 /PRNewswire/ -- A groundbreaking new study published in NeuroImage: Reports demonstrates that whole-brain Single Photon Emission Computed Tomography (SPECT) imaging, combined with adva…